Conference programme
ESCAIDE 2019 – provisional programme
(as of 11 October 2019)
Download the detailed overview of the parallel sessions on oral and poster presentations:
|
Time |
Day 1, Wednesday 27 November 2019 |
Day 2, Thursday 28 November 2019 |
Day 3, Friday 29 November 2019 |
|---|---|---|---|
|
8:15 - |
Registration & coffee |
Registration |
Registration |
|
9:00-10:30 |
Welcome (09:00- 09:15)
Plenary session A: “Health security and preparedness: lessons from Ebola"
Dr. Mike Ryan, World Health Organization, Switzerland
Chair: Prof. Mike Catchpole (ECDC) |
Plenary session C: “The microbiome: what you need to know”
Dr. Sean Gibbons, Institute for Systems Biology, United States of America Prof. Debby Bogaert, The University of Edinburgh, United Kingdom
Chairs: Dr. João André Carriço (Medical University of Lisbon, Portugal); Dr. Christopher Barbara (Mater Dei Hospital, Malta) |
Plenary session D: “How should public health research priorities be defined, and what should they be?” Dr. Ed Whiting, Wellcome Trust, United Kingdom Dr. Lina Moses, School of Public Health & Tropical Medicine/ Tulane University, United States of America Dr. Jean- Claude Desenclos, IANPHI, Public Health France
Chairs: Dr. Maria Van Kerkhove (WHO HQ); Dr. Frode Forland (Norwegian Institute of Public Health); Amrish Baidjoe (WHO-South-East Asia Regional Office) |
|
10:30-11:00 |
Poster mingle & refreshments |
Poster mingle & refreshments |
Poster mingle & refreshments |
|
11:00-12:40 |
Parallel sessions 1. Emerging and vector-borne diseases: surveillance approaches 2. Vaccine-preventable diseases: vaccine coverage, safety and uptake 3. Healthcare-associated infections: burden and prevention |
Parallel sessions 7. Food- and waterborne diseases and zoonoses: Public health microbiology and surveillance methods 8. Vaccine-preventable diseases: surveillance (1) 9. Influenza: Vaccination and intervention (1) |
Parallel sessions 16. Vaccine-preventable diseases: Epidemiology 17. Hepatitis B and C: Surveillance and disease burden 18. Food- and waterborne diseases and zoonoses outbreaks (2) |
|
12:40 -14:30 |
Lunch / Eurosurveillance seminar |
Lunch |
Lunch/ Career compass |
|
14:30-15:30 |
Parallel sessions 4. Antimicrobial resistance and healthcare-associated infections (Epidemiology) 5. Emerging and vector-borne diseases: epidemiology 6. Food- and waterborne diseases and zoonoses outbreaks (1) |
Parallel sessions 10. Antimicrobial resistance and healthcare-associated infections (Surveillance) 11. Late breakers 12. Influenza: Vaccination and intervention (2) |
Parallel sessions 19. Vaccine-preventable diseases surveillance (3) 20. Food- and waterborne diseases and zoonoses surveillance 21. Late breakers |
|
15:40-16:40 |
Moderated poster session 1. Antimicrobial resistance 2. Emerging and vector-borne diseases, and international health (1) 3. Food- and waterborne diseases and zoonoses (1): Outbreaks (I) 4. Food- and waterborne diseases and zoonoses (2): Surveillance 5. Influenza and other respiratory viruses (1) 6. HIV, sexually transmitted infections and viral hepatitis (1): Surveillance and burden of disease 7. Vaccine preventable diseases (1): Measles 8. Vaccine- preventable diseases (2): Surveillance |
Moderated poster session 9. Healthcare-associated infections 10. Emerging and vector-borne diseases, and International health (2): Vector-borne diseases 11. Food- and waterborne diseases (3): Epidemiology and Burden of disease 12. Food- and waterborne diseases and zoonoses (4): Public Health Microbiology 13. HIV, sexually transmitted infections and viral hepatitis (2): Intervention 14. Tuberculosis and other respiratory diseases (excluding viruses) (1): Surveillance and modelling 15. Influenza and other respiratory viruses (2): Vaccination and interventions 16. Vaccine- preventable diseases (2) |
Moderated poster session 17. Food- and waterborne diseases and zoonoses (5): Outbreaks (II) 18. Tuberculosis and other respiratory diseases (excluding viruses) (2): Epidemiology 19. EVD and International health (3): Surveillance approaches 20. HIV, sexually transmitted infections and viral hepatitis (III): Surveillance & Epidemiology 21. Influenza and other respiratory viruses (3): Human Respiratory Syncytial virus 22. Influenza and other respiratory viruses (4) 23. Vaccine- preventable diseases (4): Vaccine coverage, uptake and response 24. Late breakers
|
|
16:40-17:00 |
Poster mingle & refreshments |
Poster mingle & refreshments |
Poster mingle & refreshments |
|
17:00-18:30 |
Plenary session B: “Vaccine confidence in a post-factual world”
Prof. Dr. Wolfgang Gaissmaier, Social Psychology and Decision Sciences, University of Konstanz Dr. Robb Butler, WHO Regional Office for Europe
Chairs: Prof. Dr. Bojana Beović (University of Ljubljana Slovenia); Dr. Frantiska Hruba (ECDC).
|
Parallel sessions 13. HIV and STI: prevalence and prevention 14. Respiratory disease: surveillance and modelling 15. Vaccine-preventable diseases surveillance (2) |
Plenary session E: “Climate change: Addressing the public health challenge in Europe”
Dr. Henriette De Valk, Public Health France
Chairs: Dr Susan Hahné (National Institute for Public Health and the Environment) and Prof. Dr. Aura Timen (National Institute for Public Health and the Environment and Free University of Amsterdam) |
|
|
Reception (18:45- 21:00) |
BarCamp (18:45- 20:00) |
Closing Ceremony and EAN prizes award (18:30- 18:40) |